Hyperfine structure of the 4f 7 (8 S 0) 6s 7 S 3 0 level in151,153Eu II by fast ion beam — laser spectroscopy

The hyperfine structure (hfs) of the level 4f ⁷(⁸ S ⁰) 6s ⁷ S ₃ ⁰ in^151,153Eu II has been measured with collinear fast ion beam — laser spectroscopy. The hfs of the⁷ S ₃ ⁰ level has been measured with interferometric methods previously but, to our knowledge, this is the first measurement with the laser ion beam technique. In the present experiment the hfs of the 4f ⁷(⁸ S ₇ ^2/0 ) 6p _1/2 levels were also obtained. Corresponding magnetic dipole and electric quadrupole coupling constantsA andB are evaluated.     

Chemogenomic discovery of allosteric antagonists at the GPRC6A receptor

GPRC6A is a Family C G protein-coupled receptor recently discovered and deorphanized by our group. This study integrates chemogenomic ligand inference, homology modeling, compound synthesis, and pharmacological mechanism-of-action studies to disclose two noticeable results of methodological and pharmacological character: (1) chemogenomic lead identification through the first, to our knowledge, ligand inference between two different GPCR families, Families A and C; and (2) the discovery of the most selective GPRC6A allosteric antagonists discovered to date. The unprecedented inference of?pharmacological activity across GPCR families provides proof-of-concept for in?silico approaches against Family C targets based on Family A templates, greatly expanding the prospects of successful drug design and discovery. The antagonists were tested against a panel of seven Family A and C G protein-coupled receptors containing the chemogenomic binding sequence motif where some of the identified GPRC6A antagonists showed some activity. However, three compounds with at least ～3-fold selectivity for GPRC6A were discovered, which present a significant step forward compared with the previously published GPRC6A antagonists, calindol and NPS 2143, which both display ～30-fold selectivity for the calcium-sensing receptor compared to GPRC6A. The antagonists constitute novel research tools toward investigating the signaling mechanism of the GPRC6A receptor at the cellular level and serve as initial ligands for further optimization of potency and selectivity enabling future ex?vivo/in?vivo pharmacological studies.     

Transition probabilities in Sm II via optical nutation

We have measured the transition probabilities for three lines in Sm II. The measurements are made by studying optical nutation with a fast Doppler switching technique in collinear laser spectroscopy on ion beams. The recorded nutation curves are fitted to a quantum-optical theoretical model, and the transition probabilities are extracted. For all three lines, the measured transition probabilities are more accurate than those of earlier published measurements.     

Parallel electromembrane extraction in a multiwell plate

This paper describes the concept of parallel electromembrane extraction (Pa-EME) with flat membranes in a multiwell format for the first time. The setup is based on a multiwell plate and provided simultaneous and selective isolation, cleanup, and enrichment of several human plasma samples as well as LC-MS-compatible extracts within 8 min of extraction. Undiluted human plasma samples spiked with four antidepressant drugs were added to separate wells in the donor plate. Subsequently, the samples were extracted with Pa-EME. The four drugs migrated electrokinetically from undiluted human plasma through a flat polypropylene membrane impregnated with 2-nitrophenyl octyl ether, and were isolated into formic acid. Extraction time, extraction voltage, agitation rate, sample volume, and acceptor solution volume were all optimized with an experimental design. The optimal conditions were as follows: The agitation rate was 1,040 rpm, and an extraction voltage of 200 V was applied. The sample volume and acceptor solution volume was 240 and 70 μL, respectively. The extraction was continued for 8 min. Eventually, the extracts were analyzed by LC-MS/MS. The combination of Pa-EME with LC-MS/MS provided quantitation limits below the therapeutic level and reported relative standard deviations in the range 5–13 %. Linear calibration curves were obtained for all analytes, and the correlation coefficients were above 0.9974 in the range 1–400 ng mL^?1. The drug concentrations from two subjects treated with quetiapine and sertraline were successfully determined with Pa-EME combined with LC-MS/MS. Post-column infusion experiments demonstrated that Pa-EME provided extracts free from interfering matrix components.